News from Zyme and the companies we work with.
VALANX Biotech secures €3 million to advance LIV-1 ADC for metastatic triple-negative breast cancer
Foundation Fournier-Majoie and FUJIFILM Corporation join existing VC and angel investors including xista science ventures, tecnet equity and SOSV Financing advances VLX-ADC-001, a LIV-1 targeting ADC, with candidate nomination planned [...]
Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer
Investment led by T&J Meyer Family Foundation, joined by Varia Ventures, NW Angel Fund and other non-institutional investors Financing advances Combat’s HIVEC® HEAT FDA registration trial to change standard of [...]
PINCH Announces Two Major New Contract Wins as Business Growth Continues Into 2026
London, UK, 09 March 2026: PINCH is proud to announce two significant new contract wins, marking an exciting start to the year and reinforcing the company’s continued growth across workplace [...]
Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections Qualified Infectious Disease Product designation awarded for the development of antibacterials [...]
Eppendorf introduces SpinPro® centrifuge series to streamline life science research
New Eppendorf SpinPro® 6 R centrifuge maximises workflow efficiency with flexible, ‘smart’ design Centrifuge showcased in ‘on demand’ video of virtual live launch Hamburg, Germany, March 9, 2026 – Eppendorf, [...]
Cytotrait secures £3M seed funding to address global food security and sustainable agriculture
Proprietary MOSS technology enables high-level, localised gene expression to overcome current challenges in crop engineering Investment round led by Northern Gritstone, with additional contributions from UK Innovation & Science Seed [...]
Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme
Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, payors and clinical stakeholders Cambridge, UK, and Boston MA, USA, 04 March 2026: Mursla Bio, [...]
OBN Invites Life Science Leaders to Celebrate 20 Years of BioTrinity
Featuring keynotes from: Steve Bates, Executive Chair at the Office for Life Sciences, Lawrence Tallon, CEO at the MHRA & Maria Koufali, Life Sciences Industry Director at the NIHR, click [...]
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
SPT Labtech to develop an automated sample preparation platform for Illumina to further optimize the efficiency and benefits of genomic workflows in decentralized healthcare settings Builds on success of existing [...]
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of development Data [...]
Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infections Investment from the world’s largest venture capital fund focused exclusively [...]
Loughborough University and Science in Sport (SiS) extend partnership in elite sport and performance nutrition
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and Science in Sport (SiS) have announced a renewed three-year partnership, strengthening the organisations’ long-standing collaboration across elite sport and performance [...]
